Hck
Hck inhibitors are compounds that target Hematopoietic Cell Kinase (Hck), a member of the Src family of tyrosine kinases involved in immune response regulation, cell growth, and differentiation. Hck is implicated in various diseases, including leukemia, inflammation, and immune disorders. Inhibitors of Hck are essential for exploring the role of this kinase in disease progression and therapeutic intervention. At CymitQuimica, we provide Hck inhibitors to support your research in immunology, oncology, and signal transduction.
Read more
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Hck-IN-1 REF: TM-T11538CAS: 1473404-51-1 | 99.07% | 104.00 €~1,120.00 € | Wed 04 Dec 24 |
| TL02-59 REF: TM-T13186CAS: 1315330-17-6 | 95.63% | 69.00 €~903.00 € | Wed 05 Feb 25 |
Hck-IN-1
CAS:1473404-51-1
Hck-IN-1 selectively inhibits Nef:Hck, IC50: 2.8 μM; >20 μM for Hck alone. Potent HIV-1 Nef …
Formula:
C16H11ClN6O3S
Purity:
99.07%
Color and Shape:
Solid
Molecular weight:
402.81
Ref: TM-T11538
| 1mg | 104.00 € | ||
| 5mg | 217.00 € | ||
| 10mg | 345.00 € | ||
| 25mg | 566.00 € | ||
| 50mg | 824.00 € | ||
| 100mg | 1,120.00 € | ||
| 1mL*10mM (DMSO) | 240.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
TL02-59
CAS:1315330-17-6
TL02-59: Fgr inhibitor (IC50=0.03nM), also targets Lyn (0.1nM), Hck (160nM), halts acute myelogenous leukemia growth.
Formula:
C32H34F3N5O4
Purity:
95.63%
Color and Shape:
Solid
Molecular weight:
609.64
Ref: TM-T13186
| 1mg | 69.00 € | ||
| 5mg | 130.00 € | ||
| 10mg | 205.00 € | ||
| 25mg | 346.00 € | ||
| 50mg | 493.00 € | ||
| 100mg | 671.00 € | ||
| 200mg | 903.00 € | ||
| 1mL*10mM (DMSO) | 169.00 € |
Estimated delivery in United States, on Wednesday 5 Feb 2025
